Gene-Guided cancer care: new trials aim to stop endometrial cancer return
NCT ID NCT05255653
First seen May 20, 2026 · Last updated Jun 13, 2026 · Updated 5 times
Summary
This study tests new treatments for endometrial cancer based on the genetic makeup of each person's tumor. About 1,615 participants will be assigned to one of four trials depending on their cancer's molecular profile. The goal is to see if these tailored therapies can prevent the cancer from coming back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Amphia Ziekenhuis
RECRUITINGBreda, Netherlands
Contact Email: •••••@•••••
-
Amsterdam University Medical Center
RECRUITINGAmsterdam, Netherlands
Contact
Contact Email: •••••@•••••
-
Catharina Ziekenhuis
RECRUITINGEindhoven, Netherlands
Contact Email: •••••@•••••
-
Erasmus Medical Center
RECRUITINGRotterdam, Netherlands
Contact Email: •••••@•••••
-
Haags Medisch Centrum
RECRUITINGThe Hague, Netherlands
Contact Email: •••••@•••••
-
Instituut Verbeeten
RECRUITINGBreda, Netherlands
Contact Email: •••••@•••••
-
Medisch Spectrum Twente
RECRUITINGEnschede, Netherlands
Contact Email: •••••@•••••
-
The MMRd-GREEN trial: Leiden University Medical Center
RECRUITINGLeiden, 2333ZA, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The NSMP-ORANGE trial: Barts Health NHS Trust
NOT_YET_RECRUITINGLondon, United Kingdom
Contact Email: •••••@•••••
-
The NSMP-ORANGE trial: Manchester Academic Health Science Centre, St Mary's Hospita
NOT_YET_RECRUITINGManchester, United Kingdom
Contact Email: •••••@•••••
-
The POLEmut-BLUE trial: Princess Margaret Cancer Centre, University of Toronto
RECRUITINGToronto, Canada
Contact Email: •••••@•••••
-
The POLEmut-BLUE trial: University of British Columbia
RECRUITINGVancouver, Canada
Contact Email: •••••@•••••
-
The p53abn-RED trial: Institute Gustave Roussy
NOT_YET_RECRUITINGVillejuif, France
Contact Email: •••••@•••••
-
Universitair Medisch Centrum Groningen
RECRUITINGGroningen, Netherlands
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.